Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma

Author: Sugiura Hideshi   Fujiwara Yasuhiro   Ando Masashi   Kawai Akira   Ogose Akira   Ozaki Toshifumi   Yokoyama Ryohei   Hiruma Toru   Ishii Takeshi   Morioka Hideo   Mugishima Hideo  

Publisher: Springer Publishing Company

ISSN: 0949-2658

Source: Journal of Orthopaedic Science, Vol.15, Iss.5, 2010-09, pp. : 654-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content